ACRUX Trademark

Trademark Overview


On Wednesday, August 20, 2008, a trademark application was filed for ACRUX with the United States Patent and Trademark Office. The USPTO has given the ACRUX trademark a serial number of 79061152. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, August 21, 2018. This trademark is owned by Acrux DDS Pty Ltd. The ACRUX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and medicated compositions for topical and transdermal applications, in the form of solutions, lotions, creams, gels, sticks, sprays, matrix patches, reservoir patches, drug-in-adhesive patches, impregnated pads, ointments, pastes, mousses, and aerosols for use in the treatment of dermatological, cardiovascular, haematological, bone, respiratory, central nervous system, peripheral nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscles and/or rheumatic disorders, immune system disorders and related diseases, allergic reactions, pain, emesis, obesity, transplanted organ rejection, epilepsy, metabolic disorders, addictive disorders, eating disorders, mental health disorders, infections, ocular disorders, and for use in oncology and contraception; topical and transdermal medicated skin preparations and pharmaceutical compositions for spray ...
acrux

General Information


Serial Number79061152
Word MarkACRUX
Filing DateWednesday, August 20, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, August 21, 2018
Registration Number3752416
Registration DateTuesday, February 23, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 8, 2009

Trademark Statements


Goods and ServicesPharmaceutical preparations and medicated compositions for topical and transdermal applications, in the form of solutions, lotions, creams, gels, sticks, sprays, matrix patches, reservoir patches, drug-in-adhesive patches, impregnated pads, ointments, pastes, mousses, and aerosols for use in the treatment of dermatological, cardiovascular, haematological, bone, respiratory, central nervous system, peripheral nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscles and/or rheumatic disorders, immune system disorders and related diseases, allergic reactions, pain, emesis, obesity, transplanted organ rejection, epilepsy, metabolic disorders, addictive disorders, eating disorders, mental health disorders, infections, ocular disorders, and for use in oncology and contraception; topical and transdermal medicated skin preparations and pharmaceutical compositions for spray application to the skin, in the form of solutions, lotions, creams, gels, sticks, sprays, matrix patches, reservoir patches, drug-in-adhesive patches, impregnated pads, ointments, pastes, mousses and aerosols for use in the treatment of dermatological, cardiovascular, haematological, bone, respiratory, central nervous system, peripheral nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscles and/or rheumatic disorders, immune system disorders and related diseases, allergic reactions, pain, emesis, obesity, transplanted organ rejection, epilepsy, metabolic disorders, addictive disorders, eating disorders, mental health disorders, infections, ocular disorders, and for use in oncology and contraception; pharmaceutical preparations for transdermal delivery, in the form of solutions, lotions, creams, gels, sticks, sprays, matrix patches, reservoir patches, drug-in-adhesive patches, impregnated pads, ointments, pastes, mousses and aerosols for use in the treatment of dermatological, cardiovascular, haematological, bone, respiratory, central nervous system, peripheral nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscles and/or rheumatic disorders, immune system disorders and related diseases, allergic reactions, pain, emesis, obesity, transplanted organ rejection, epilepsy, metabolic disorders, addictive disorders, eating disorders, mental health disorders, infections, ocular disorders, and for use in oncology and contraception

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 30, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAcrux DDS Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAU

Party NameAcrux DDS Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAU

Party NameAcrux DDS Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAU

Trademark Events


Event DateEvent Description
Friday, March 15, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, March 15, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, June 30, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, June 1, 2017TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, June 1, 2017INVALIDATION PROCESSED
Tuesday, May 30, 2017TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 30, 2016CANCELLED SECTION 71
Wednesday, February 6, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 14, 2010FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 14, 2010FINAL DISPOSITION PROCESSED
Sunday, May 23, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 23, 2010REGISTERED-PRINCIPAL REGISTER
Wednesday, January 13, 2010LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Tuesday, December 8, 2009PUBLISHED FOR OPPOSITION
Monday, November 30, 2009LIMITATION OF GOODS RECEIVED FROM IB
Wednesday, November 18, 2009NOTICE OF PUBLICATION
Tuesday, November 3, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 2, 2009EXAMINERS AMENDMENT MAILED
Friday, October 30, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 30, 2009EXAMINER'S AMENDMENT ENTERED
Friday, October 30, 2009EXAMINERS AMENDMENT -WRITTEN
Tuesday, August 4, 2009NON-FINAL ACTION MAILED
Tuesday, August 4, 2009NON-FINAL ACTION WRITTEN
Wednesday, July 8, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 8, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 8, 2009ASSIGNED TO LIE
Friday, June 26, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 26, 2009PETITION TO REVIVE-GRANTED
Friday, June 26, 2009TEAS PETITION TO REVIVE RECEIVED
Friday, January 23, 2009REFUSAL PROCESSED BY IB
Thursday, December 11, 2008NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, December 11, 2008REFUSAL PROCESSED BY MPU
Thursday, December 11, 2008NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, December 10, 2008NON-FINAL ACTION WRITTEN
Tuesday, December 2, 2008APPLICATION FILING RECEIPT MAILED
Monday, December 1, 2008ASSIGNED TO EXAMINER
Friday, November 28, 2008NEW APPLICATION ENTERED IN TRAM
Thursday, November 27, 2008SN ASSIGNED FOR SECT 66A APPL FROM IB